Ardelyx, Inc. - Common Stock (NQ:ARDX)

3.050 -0.030 (-0.97%)

Delayed Quote Updated: 11:12 AM EDT, Oct 26, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ardelyx, Inc. - Common Stock

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 20, 2021

Gainers Enveric Biosciences (NASDAQ:ENVB)...

Via Benzinga

55 Biggest Movers From Friday ↗

May 03, 2021

Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) jumped 45.5% to close at $49.80 on Friday after dropping around 22% on Thursday. Brooklyn ImmunoTherapeutics acquired...

Via Benzinga

Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗

May 01, 2021

Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 30, 2021

Gainers Motus GI Hldgs (NASDAQ:MOTS) stock moved upwards by 30.17% to $1.42 during Friday's regular session. As of 12:31 EST, this security is trading at a volume of...

Via Benzinga

38 Stocks Moving In Friday's Mid-Day Session ↗

April 30, 2021

Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 29.2% to $5.93 after the company announced it initiated a quarterly dividend of $0.12 per share, authorized a 220,000...

Via Benzinga

Why Ardelyx Stock Is Sinking Today ↗

April 30, 2021

The FDA pushed back its approval decision for the company's lead candidate.

Via The Motley Fool

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 30, 2021

Gainers Motus GI Hldgs (NASDAQ:MOTS) stock increased by 46.78% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $74.7...

Via Benzinga

The Daily Biotech Pulse: Hyperphosphatemia Drug Regulatory Review Extended, Phathom Pharma Data Readout, 2 IPOs ↗

April 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 29) AtriCure, Inc. (NASDAQ:...

Via Benzinga

22 Stocks Moving in Friday's Pre-Market Session ↗

April 30, 2021

Gainers Image Sensing Systems, Inc. (NASDAQ: ISNS) rose 30.7% to $6.00 in pre-market trading after the company announced it initiated a quarterly dividend of $0.12 per share,...

Via Benzinga

Ardelyx Stock Plummets As Review Period For Tenapanor US Application Pushed By 3 Months ↗

April 30, 2021

The FDA has extended the Prescription Drug User Fee Act (PDUFA) date for Ardelyx Inc's (NASDAQ: ARDX) tenapanor for the control of serum phosphorus...

Via Benzinga

15 Stocks Moving In Thursday's After-Hours Session ↗

April 29, 2021

Gainers Amazon (NASDAQ: AMZN) shares are trading higher after the company reported better-than-expected Q1 EPS and sales results. The company also issued Q2 sales guidance above...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 20, 2021

Gainers MyMD Pharmaceuticals, Inc. - Common Stock (NASDAQ:MYMD) shares moved upwards by 14.12% to $5.1 during Tuesday's regular session. As of 12:31 EST, this security...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 16, 2021

Gainers BioCryst Pharmaceuticals (NASDAQ:BCRX) shares rose 11.13% to $11.32 during Friday's regular session. As of 08:06 EST, this security is trading at a volume of 8...

Via Benzinga

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs ↗

April 16, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 15) Ardelyx, Inc. (NASDAQ:...

Via Benzinga

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

42 Biggest Movers From Yesterday ↗

April 16, 2021

Gainers Esports Technologies, Inc. (NASDAQ: EBET) shares jumped 507% to settle at $36.42 on Thursday. agilon health, inc. (NYSE: AGL) gained 34.8% to close at $31.00 after the...

Via Benzinga

Mid-Day Market Update: Dow Surges 250 Points; KLX Energy Services Shares Slide ↗

April 15, 2021

Midway through trading Thursday, the Dow traded up 0.75% to 33,983.24 while the NASDAQ rose 1.02% to 13,999.22. The S&P also rose, gaining 0.85% to 4,159.64. The U.S. has the...

Via Benzinga

Topics Stocks

30 Stocks Moving In Thursday's Mid-Day Session ↗

April 15, 2021

Gainers Wilhelmina International, Inc. (NASDAQ: WHLM) shares jumped 58.2% to $13.16 after gaining 14% on Wednesday. The company's 13D filing recently showed that Modell'...

Via Benzinga

Why Ardelyx Stock Soared Today ↗

April 14, 2021

The company's Japanese partner initiated pivotal late-stage studies of Ardelyx's lead candidate.

Via The Motley Fool

The Daily Biotech Pulse: FibroGen Fudges Safety Data, Novartis Strikes Cancer Drug Collaboration, Immutep Gains On Patent Award ↗

April 07, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 6) AngioDynamics, Inc. (NASDAQ...

Via Benzinga

Topics Intellectual Property

< Previous 1 2

...

16 17 18 19 20 21 22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.